These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1135 related items for PubMed ID: 16638059

  • 1. [Post-marketing surveillance on treatment of 5,665 patients with atopic dermatitis using the calcineurin inhibitor pimecrolimus: positive effects on major symptoms of atopic dermatitis and on quality of life].
    Sunderkötter C, Weiss JM, Bextermöller R, Löffler H, Schneider D.
    J Dtsch Dermatol Ges; 2006 Apr; 4(4):301-6. PubMed ID: 16638059
    [Abstract] [Full Text] [Related]

  • 2. Treatment of paediatric atopic dermatitis with pimecrolimus (Elidel, SDZ ASM 981): impact on quality of life and health-related quality of life.
    McKenna SP, Whalley D, de Prost Y, Staab D, Huels J, Paul CF, van Assche D.
    J Eur Acad Dermatol Venereol; 2006 Mar; 20(3):248-54. PubMed ID: 16503881
    [Abstract] [Full Text] [Related]

  • 3. A randomized study of the safety, absorption and efficacy of pimecrolimus cream 1% applied twice or four times daily in patients with atopic dermatitis.
    Ling M, Gottlieb A, Pariser D, Caro I, Stewart D, Scott G, Abrams K.
    J Dermatolog Treat; 2005 Aug; 16(3):142-8. PubMed ID: 16096179
    [Abstract] [Full Text] [Related]

  • 4. Effect of sequential applications of topical tacrolimus and topical corticosteroids in the treatment of pediatric atopic dermatitis: an open-label pilot study.
    Kubota Y, Yoneda K, Nakai K, Katsuura J, Moriue T, Matsuoka Y, Miyamoto I, Ohya Y.
    J Am Acad Dermatol; 2009 Feb; 60(2):212-7. PubMed ID: 19027990
    [Abstract] [Full Text] [Related]

  • 5. Impact of topical calcineurin inhibitors on quality of life in patients with atopic dermatitis.
    Ingram JR, Martin JA, Finlay AY.
    Am J Clin Dermatol; 2009 Feb; 10(4):229-37. PubMed ID: 19489656
    [Abstract] [Full Text] [Related]

  • 6. Two topical calcineurin inhibitors for the treatment of atopic dermatitis in pediatric patients: a meta-analysis of randomized clinical trials.
    Chen SL, Yan J, Wang FS.
    J Dermatolog Treat; 2010 May; 21(3):144-56. PubMed ID: 20394490
    [Abstract] [Full Text] [Related]

  • 7. Safety and efficacy of pimecrolimus cream 1% in the daily practice: results of a patient self-observation study in patients with atopic dermatitis.
    Luger TA, Gollnick H, Schwennesen T, Bextermöller R, Freytag S, Bräutigam M.
    J Dtsch Dermatol Ges; 2007 Oct; 5(10):908-14. PubMed ID: 17910673
    [Abstract] [Full Text] [Related]

  • 8. Review of pimecrolimus cream 1% for the treatment of mild to moderate atopic dermatitis.
    Hebert AA.
    Clin Ther; 2006 Dec; 28(12):1972-82. PubMed ID: 17296454
    [Abstract] [Full Text] [Related]

  • 9. Safety and efficacy of early intervention with pimecrolimus cream 1% combined with corticosteroids for major flares in infants and children with atopic dermatitis.
    Siegfried E, Korman N, Molina C, Kianifard F, Abrams K.
    J Dermatolog Treat; 2006 Dec; 17(3):143-50. PubMed ID: 16854753
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Pharmacokinetics of topical calcineurin inhibitors in adult atopic dermatitis: a randomized, investigator-blind comparison.
    Draelos Z, Nayak A, Pariser D, Shupack JL, Chon K, Abrams B, Paul CF.
    J Am Acad Dermatol; 2005 Oct; 53(4):602-9. PubMed ID: 16198779
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Belgian observational drug utilization study of pimecrolimus cream 1% in routine daily practice in atopic dermatitis.
    De Backer M, Morren MA, Boonen H, Boyden B, Vertruyen A, Lecomte P, Paquay C, Lesaffre E, Lambert J.
    Dermatology; 2008 Oct; 217(2):156-63. PubMed ID: 18525202
    [Abstract] [Full Text] [Related]

  • 19. Low systemic absorption and good tolerability of pimecrolimus, administered as 1% cream (Elidel) in infants with atopic dermatitis--a multicenter, 3-week, open-label study.
    Staab D, Pariser D, Gottlieb AB, Kaufmann R, Eichenfield LF, Langley RG, Scott G, Ebelin ME, Barilla D, Schmidli H, Burtin P.
    Pediatr Dermatol; 2005 Oct; 22(5):465-71. PubMed ID: 16191004
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 57.